On the afternoon of April 25, 2018, the 2017 Shenzhen CSR Evaluation Certification ceremony was held in Shenzhen Civic Center. Star Silver Medicine won the three-star evaluation certificate.
The evaluation activity was launched in March 2017, a total of 105 enterprises participated in the review, and 6 enterprises were disqualified due to illegal and irregular verification during the review process, and 9 enterprises were automatically withdrawn midway and did not reach the star level. After the professional certification body inspection and evaluation data and to the enterprise on-site evaluation, the relevant government departments verified and publicized, and finally rated 89 enterprises above the star level (of which 42 three-star, 41 two-star and 6 one-star). Among the 42 companies that received three stars in the evaluation, Xingyin Pharmaceutical ranked third.
Judging from the scoring results, the efforts made by Xingyin Medicine in social responsibility have been unanimously recognized by review experts and all sectors of society. An enterprise must have economic responsibility, legal responsibility, social responsibility and moral responsibility. The bigger the enterprise, the greater the social responsibility and moral responsibility. Only the enterprises that actively undertake social responsibility are the enterprises with competitiveness and vitality. On the way of development, Xingyin Pharmaceutical will continue to fulfill its corporate social responsibility as always.